---
title: "Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp"
date: "2024-01-03T09:43:13.000Z"
publishedDate: "3 janvier 2024"
summary: "Pulse Biosciences has filed a premarket notification 510(k) to the US Food and Drug Administration (FDA) for its novel CellFX nanosecond pulsed field ablation (nsPFA) cardiac clamp. Pursuant to Section 510(k), once the application has been accepted, the FDA will conduct its substantive review and may request additional information from the company based on that [&#8230;] The post Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/pulse-biosciences-files-premarket-us-fda-510k-notification-for-its-cellfx-nspfa-cardiac-clamp/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-03-pulse-biosciences-files-premarket-us-fda-510k-notification-for-its-cellfx-nspfa-cardiac-clamp"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/US-FDA-HQ.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pulse-biosciences-files-premarket-us-fda-510k-notification-for-its-cellfx-nspfa-cardiac-clamp/"
---

![Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/01/US-FDA-HQ.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pulse-biosciences-files-premarket-us-fda-510k-notification-for-its-cellfx-nspfa-cardiac-clamp/*

## L’essentiel

Pulse Biosciences has filed a premarket notification 510(k) to the US Food and Drug Administration (FDA) for its novel CellFX nanosecond pulsed field ablation (nsPFA) cardiac clamp. Pursuant to Section 510(k), once the application has been accepted, the FDA will conduct its substantive review and may request additional information from the company based on that [&#8230;] The post Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/pulse-biosciences-files-premarket-us-fda-510k-notification-for-its-cellfx-nspfa-cardiac-clamp/
